Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Giulia Carreras

Biographic Data

ID7700960
NAMEGiulia Carreras
GIVEN NAMESGiulia
FAMILY NAMECarreras
SIGNATURECARRERAS G
AFFILIATIONSPiedmont Reference Center for Epidemiology and Cancer Prevention
ORCID0000-0002-1427-637X
VERIFIEDYes
TOTAL WORKS38
TOTAL CITATIONS0
AUTHOR COUNT38
EDITOR COUNT0
FIRST PUBLICATION YEAR2011
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Testing feedback and social norms messages to increase participation: The BestCC randomized controlled trial among non-respondents in population-based colorectal cancer screening programmes in Tuscany

    Open Access•Giuseppe Gorini, Elisa Betti et al.•ARTICLE•SSM - Population Health•2026

  • What is the best tobacco control policy in Tuscany? An assessment using uncertainty analysis

    Alessio Lachi, Giulia Carreras et al.•ARTICLE•Tobacco Control•2026

    The approach shows promise for identifying key sources of uncertainty and guiding public health strategies. Although uncertainty limits the precise quantification of future dynamics and impacts, the TCP1 is likely to exert the strongest long-term effect on reducing smoking prevalence, while cessation interventions remain essential for achieving short-term reductions in smoking-attributable mortality

  • Burden of disease scenarios for 204 countries and territories, 2022–2050: A forecasting analysis for the Global Burden of Disease Study 2021

    Open Access•Stein Emil Vollset, Hazim S Ababneh et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Future trends in disease burden and drivers of health are of great interest to policy makers and the public at large. This information can be used for policy and long-term health investment, planning, and prioritisation. We have expanded and improved upon previous forecasts produced as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) and provide a reference forecast (the most likely future), and alternativ…

  • Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021

    Open Access•Michael Brauer, Gregory A Roth et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Understanding the health consequences associated with exposure to risk factors is necessary to inform public health policy and practice. To systematically quantify the contributions of risk factor exposures to specific health outcomes, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 aims to provide comprehensive estimates of exposure levels, relative health risks, and attributable burden of disease for 88 ri…

  • Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: A comprehensive demographic analysis for the Global Burden of Disease Study 2021

    Open Access•Natalia V Bhattacharjee, Austin E Schumacher et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Accurate assessments of current and future fertility-including overall trends and changing population age structures across countries and regions-are essential to help plan for the profound social, economic, environmental, and geopolitical challenges that these changes will bring. Estimates and projections of fertility are necessary to inform policies involving resource and health-care needs, labour supply, education, gender equality,…

  • Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease…

    Open Access•Mohsen Naghavi, Kanyin Liane Ong et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mort…

  • Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the Covid-19 pandemic: A compr…

    Open Access•Austin E Schumacher, Hmwe Hmwe Kyu et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 cou…

  • Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (Dalys), and healthy life expectancy (Hale) for 371 diseases and injuries in 204 countries and territor…

    Open Access•Alize J Ferrari, Damian Francesco Santomauro et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to im…

  • Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021

    Open Access•Jaimie D Steinmetz, Katrin Seeher et al.•ARTICLE•The Lancet Neurology•2024

    BACKGROUND: Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by…

  • Prevention Lab: A predictive model for estimating the impact of prevention interventions in a simulated Italian cohort

    Open Access•Leonardo Cianfanelli, Carlo Senore et al.•ARTICLE•BMC Public Health•2024

    We propose a Markovian model to estimate how interventions on smoking and sedentary lifestyle can affect the reduction of the disease burden, and validate the model on historical data. The model is flexible and allows to extend the analysis to consider more risk factors in future research. However, we are aware that, given the ever-increasing availability of data, it is necessary in the future to increase the complexity of the model, to be closer…

  • The state of health in the European Union (EU-27) in 2019: A systematic analysis for the Global Burden of Disease study 2019

    Open Access•João Vasco Santos, Alicia Padron-Monedero et al.•ARTICLE•BMC Public Health•2024

    There was a clear trend towards improvement in the overall health status of the EU but with differences between countries. EU health policymakers need to address the burden of diseases, paying specific attention to causes such as mental disorders. There are many opportunities for mutual learning among otherwise similar countries with different patterns of disease

  • Impact of the 2008 economic crisis on the burden of hepatitis B and C diseases in Southern European countries

    Open Access•Claudia Palladino, Rebeca Ramis et al.•ARTICLE•BMC Public Health•2024

    Epidemiological metrics for HBV and HCV showed a slower pace of decline in the post-austerity period with better improvement for HBV, a stabilisation of mortality and a stagnant burden for liver cancer due to both hepatitis infections. The economic crisis of 2008 had a negative impact on the burden of hepatitis B and C. Elimination of HBV and HCV by 2030 will be a major challenge in the SWE countries

  • Lung cancer and smoking: Years lived with disability in Tuscany (Italy). An analysis from the Acab study

    Open Access•Maria Chiara Malevolti, Michela Baccini et al.•ARTICLE•BMC Public Health•2024

    The updated estimates of the burden of LC attributable to smoking for the Tuscany region as a whole and for each LHU provide indications to inform strategic prevention plans and set public health priorities. The impact of smoking on YLDs from LC is not negligible and heterogeneous by LHU, thus requiring local interventions

  • Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of …

    Open Access•Global Burden of Disease Cancer Collaboration, Jonathan Kocarnik et al.•ARTICLE•JAMA Oncology•2022

    IMPORTANCE: The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. OBJECTIVE: To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. EVIDENCE REVIEW: The GBD 2019 estimation methods were used t…

  • Impact of electronic cigarette and heated tobacco product on conventional smoking: An Italian prospective cohort study conducted during the Covid-19 pandemic

    Silvano Gallus, Chiara Stival et al.•ARTICLE•Tobacco Control•2022

    Both e-cigarette and HTP use predict starting smoking and relapse, and appear to reduce smoking cessation. Due to the limited sample size within specific strata, the association with quitting smoking should be confirmed by larger prospective studies. These findings do not support the use of e-cigarettes and HTPs in tobacco control as a consumer product, at least in Italy

  • Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: All-cause and cause-specific mortality findings from the Global Burden of Disease Study …

    Open Access•Katherine R Paulson, Katherine Paulson et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, a…

  • Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: A systematic analysis from the Global Burd…

    Open Access•Marissa B Reitsma, Parkes J Kendrick et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. METHODS: We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global B…

  • The impact of Covid-19 lockdown on gambling habit: A cross-sectional study from Italy

    Open Access•Alessandra Lugo, Chiara Stival et al.•ARTICLE•Journal of Behavioral Addictions•2021

  • Impact of Covid-19 lockdown on smoking consumption in a large representative sample of Italian adults

    Open Access•Giulia Carreras, Alessandra Lugo et al.•ARTICLE•Tobacco Control•2021

    COVID-19 lockdown had a huge impact on smoking consumption of the Italian general population. The main concern is for smokers who increase their cigarette consumption due to an increased mental distress. Providing greater resources for cessation services capable of reducing mental health symptoms in smokers is urgently needed

  • Global age-sex-specific fertility, mortality, healthy life expectancy (Hale), and population estimates in 204 countries and territories, 1950–2019: A comprehensive demographic analysis for the Global …

    Open Access•Haidong Wang, Kaja Abbas et al.•ARTICLE•The Lancet•2020

    BACKGROUND: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected sub…

  • Five insights from the Global Burden of Disease Study 2019

    Open Access•Christopher J L Murray, Cristiana Abbafati et al.•ARTICLE•The Lancet•2020

  • Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study…

    Open Access•R Lozano, Nancy Fullman et al.•ARTICLE•The Lancet•2020

    BACKGROUND: Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system le…

  • Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019

    Open Access•Christopher J L Murray, Aleksandr Y Aravkin et al.•ARTICLE•The Lancet•2020

    BACKGROUND: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attribu…

  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019

    Open Access•Theo Vos, Stephen S Lim et al.•ARTICLE•The Lancet•2020

    BACKGROUND: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive…

  • Tackling second-hand exposure to tobacco smoke and aerosols of electronic cigarettes: The TackSHS project protocol

    Open Access•Esteve Fernandez, María J López et al.•ARTICLE•Gaceta Sanitaria•2020

    The TackSHS project aims to comprehensively elucidate the impact that exposure to second-hand smoke (SHS) from cigarettes and second-hand aerosols (SHA) from electronic cigarettes have on the respiratory health of the European population according to socioeconomic characteristics and other determinants. The TackSHS project involves a series of coordinated studies carried out by 11 academic and public health organisations from six European countri…

Next

No prominent works on this page.

  • The Pap smear screening as an occasion for smoking cessation and physical activity counselling: Baseline characteristics of women involved in the SPRINT randomized controlled trial

    Open Access•Elisabetta Chellini, Giuseppe Gorini et al.•ARTICLE•BMC Public Health•2011

    ISRCTN: ISRCTN52660565

  • Estimating the probabilities of making a smoking quit attempt in Italy: Stall in smoking cessation levels, 1986-2009

    Open Access•Giulia Carreras, Silvano Gallus et al.•ARTICLE•BMC Public Health•2012

    Over the last 20 years, cessation probabilities among Italian smokers, particularly for those aged 30-59 years, have been very low and stalled. Quitting in Italy is considered as a practicable strategy only by women in the age of pregnancy and by elderly persons, when it's likely that symptoms of tobacco-related diseases have already appeared. In order to increase cessation probabilities, smoking cessation treatment policies (introducing total re…

  • Italy SimSmoke: The effect of tobacco control policies on smoking prevalence and smoking attributable deaths in Italy

    Open Access•David T Levy, David Levy et al.•ARTICLE•BMC Public Health•2012

    Besides presenting the benefits of a comprehensive tobacco control strategy, the model helps identify information gaps in surveillance and evaluation schemes that will promote the effectiveness of future tobacco control policy in Italy

  • The Pap smear screening as an occasion for smoking cessation and physical activity counselling: Effectiveness of the SPRINT randomized controlled trial

    Open Access•Giuseppe Gorini, Giulia Carreras et al.•ARTICLE•BMC Public Health•2012

    Current Controlled Trials ISRCTN52660565

  • Time Trends of Italian Former Smokers 1980–2009 and 2010–2030 Projections Using a Bayesian Age Period Cohort Model

    Open Access•Giulia Carreras, Giuseppe Gorini•ARTICLE•International Journal of…•2013

    This study aimed to describe past time trends of the prevalence of former smokers in Italy and to estimate prevalence projections using a Bayesian approach. An age-period-cohort (APC) analysis has been carried out in order to investigate the effect of the age, period and birth cohort on the prevalence of former smokers during 1980-2009. A Bayesian APC model with an autoregressive structure for the age, period and cohort parameters has been used t…

  • Life Gain in Italian Smokers Who Quit

    Open Access•Laura Carrozzi, Franco H Falcone et al.•ARTICLE•International Journal of…•2014

    This study aims to estimate the number of life years gained with quitting smoking in Italian smokers of both sexes, by number of cigarettes smoked per day (cig/day) and age at cessation. All-cause mortality tables by age, sex and smoking status were computed, based on Italian smoking data, and the survival curves of former and current smokers were compared. The more cig/day a man/woman smokes, and the younger his/her age of quitting smoking, the …

  • Impact of National Smoke-Free Legislation on Educational Disparities in Smoke-Free Homes: Findings from the Sidriat Longitudinal Study

    Open Access•Giuseppe Gorini, Giulia Carreras et al.•ARTICLE•International Journal of…•2015

    Families with lower socioeconomic status are less likely to adopt household smoking bans (HSB). The aim of this study was to determine whether socioeconomic disparities in HSB prevalence in Italy decreased 7-9 years after the introduction of the Italian ban on smoking in public places. A longitudinal, 12-year, two-wave study was conducted on a sample of 3091 youths aged 6-14 years in 2002; 1763 (57%) were re-interviewed in 2012-2014. A Poisson re…

  • Socioeconomic disparities in quitting smoking and in steps on the smoking cessation pathway among smokers in Italy: Findings from the Sidriat cohort study

    Giuseppe Gorini, Giulia Carreras et al.•ARTICLE•Addiction Research & Theory•2017

    Objectives: The aim of this research was to examine socioeconomic disparities in quitting smoking and the association between socioeconomic status (SES) and steps in the smoking cessation pathway.Methods: We conducted an 11-year longitudinal cohort study examining the association between SES and quitting smoking among 721 current smokers at baseline. At the follow-up survey there were 466 smokers composed by those who continued smoking since base…

  • Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: A systematic analysis for the Global Burden of Disease Study 2017

    Open Access•Daniel Dicker, Grant Nguyen et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent wit…

  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2017

    Open Access•Gregory A Roth, D Abate et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD …

  • Alcohol use and burden for 195 countries and territories, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016

    Open Access•Max Griswold, Max G Griswold et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Alcohol use is a leading risk factor for death and disability, but its overall association with health remains complex given the possible protective effects of moderate alcohol consumption on some conditions. With our comprehensive approach to health accounting within the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we generated improved estimates of alcohol use and alcohol-attributable deaths and disability-adjus…

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A s…

    Open Access•Jeffrey D Stanaway, Ashkan Afshin et al.•ARTICLE•The Lancet•2018

    BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk–outcome pairs, and new data on risk exposure levels and risk–outcome associatio…

  • Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysi…

    Open Access•Christina Fitzmaurice, Global Burden of Disease Cancer Collaboration et al.•ARTICLE•JAMA Oncology•2019

    Importance Cancer and other noncommunicable diseases (NCDs) are now widely recognized as a threat to global development. The latest United Nations high-level meeting on NCDs reaffirmed this observation and also highlighted the slow progress in meeting the 2011 Political Declaration on the Prevention and Control of Noncommunicable Diseases and the third Sustainable Development Goal. Lack of situational analyses, priority setting, and budgeting hav…

  • Global age-sex-specific fertility, mortality, healthy life expectancy (Hale), and population estimates in 204 countries and territories, 1950–2019: A comprehensive demographic analysis for the Global …

    Open Access•Haidong Wang, Kaja Abbas et al.•ARTICLE•The Lancet•2020

    BACKGROUND: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected sub…

  • Five insights from the Global Burden of Disease Study 2019

    Open Access•Christopher J L Murray, Cristiana Abbafati et al.•ARTICLE•The Lancet•2020

  • Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study…

    Open Access•R Lozano, Nancy Fullman et al.•ARTICLE•The Lancet•2020

    BACKGROUND: Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system le…

  • Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019

    Open Access•Christopher J L Murray, Aleksandr Y Aravkin et al.•ARTICLE•The Lancet•2020

    BACKGROUND: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attribu…

  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019

    Open Access•Theo Vos, Stephen S Lim et al.•ARTICLE•The Lancet•2020

    BACKGROUND: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive…

  • Tackling second-hand exposure to tobacco smoke and aerosols of electronic cigarettes: The TackSHS project protocol

    Open Access•Esteve Fernandez, María J López et al.•ARTICLE•Gaceta Sanitaria•2020

    The TackSHS project aims to comprehensively elucidate the impact that exposure to second-hand smoke (SHS) from cigarettes and second-hand aerosols (SHA) from electronic cigarettes have on the respiratory health of the European population according to socioeconomic characteristics and other determinants. The TackSHS project involves a series of coordinated studies carried out by 11 academic and public health organisations from six European countri…

  • Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: All-cause and cause-specific mortality findings from the Global Burden of Disease Study …

    Open Access•Katherine R Paulson, Katherine Paulson et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, a…

  • Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: A systematic analysis from the Global Burd…

    Open Access•Marissa B Reitsma, Parkes J Kendrick et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. METHODS: We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global B…

  • The impact of Covid-19 lockdown on gambling habit: A cross-sectional study from Italy

    Open Access•Alessandra Lugo, Chiara Stival et al.•ARTICLE•Journal of Behavioral Addictions•2021

  • Impact of Covid-19 lockdown on smoking consumption in a large representative sample of Italian adults

    Open Access•Giulia Carreras, Alessandra Lugo et al.•ARTICLE•Tobacco Control•2021

    COVID-19 lockdown had a huge impact on smoking consumption of the Italian general population. The main concern is for smokers who increase their cigarette consumption due to an increased mental distress. Providing greater resources for cessation services capable of reducing mental health symptoms in smokers is urgently needed

  • Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of …

    Open Access•Global Burden of Disease Cancer Collaboration, Jonathan Kocarnik et al.•ARTICLE•JAMA Oncology•2022

    IMPORTANCE: The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. OBJECTIVE: To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. EVIDENCE REVIEW: The GBD 2019 estimation methods were used t…

  • Impact of electronic cigarette and heated tobacco product on conventional smoking: An Italian prospective cohort study conducted during the Covid-19 pandemic

    Silvano Gallus, Chiara Stival et al.•ARTICLE•Tobacco Control•2022

    Both e-cigarette and HTP use predict starting smoking and relapse, and appear to reduce smoking cessation. Due to the limited sample size within specific strata, the association with quitting smoking should be confirmed by larger prospective studies. These findings do not support the use of e-cigarettes and HTPs in tobacco control as a consumer product, at least in Italy

Medicine (35 works) · Environmental health (30 works) · Population (23 works) · Demography (20 works) · Disease (17 works) · Public health (16 works) · Burden of disease (14 works) · Pathology (12 works) · Smoking Behavior and Cessation (12 works) · Disease burden (11 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae